Franklin Biotechnology Discovery Fund Class A (FBDIX)

126.03
Net Asset Value
-0.06%
1 Day
-3.82%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
5.75
Sales Expenses
1.22%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. It predominantly invests in equity securities, primarily common stock. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of foreign or U.S. issuer. It is non-diversified.

Performance

1 month-17.50% 3 years+27.32%
3 months-13.81% 5 years+25.25%
1 year+31.84% Since inception+12.57%
Data through --

Peer Comparisonvs. Health

 FBDIXCategory
Performance 5-yr return+25.25%+23.71%
Expense ratio1.22%1.46%
Risk 5 year sharpe ratio1.331.54
Net assets$1.5B$2.6B
Average market cap$9.4B$31.7B
Average P/E32.426.8
Portfolio turnover34%34%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFranklin Templeton Investments
Fund manager & tenureEvan McCulloch / 16 Years
Minimal initial investment$1,000.00
Minimum IRA investment$250.00

Holdings

U.S. stock90.65%
Cash5.87%
International stock3.16%
Fixed income0.32%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences Inc9.94%
CELG Celgene Corporation9.75%
BIIB Biogen Idec Inc6.77%
AMGN Amgen Inc6.22%
MDVN Medivation, Inc.4.10%
REGN Regeneron Pharmaceuticals, Inc.3.84%
ALXN Alexion Pharmaceuticals, Inc.3.61%
INCY Incyte Corp Ltd3.03%
VRTX Vertex Pharmaceuticals2.93%
BMRN Biomarin Pharmaceutical, Inc.2.61%

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.